Abstract
Obesity, a chronic metabolic disease with a complex pathophysiology, is caused by several variables. High-fat diets lead to the disruption of the gut microbiota and impaired gut barrier function in obese people. The dysbiosis and its metabolites through the intestinal barrier lead to an imbalance in energy metabolism and inflammatory response, which eventually contributes to the development of chronic diseases such as diabetes, hypertension, and cardiovascular disease. Current medicines are therapeutic to obesity in the short term; however, they may bring significant physical and emotional problems to patients as major side effects. Therefore, it is urgent to explore new therapeutic methods that have definite efficacy, can be taken for a long time, and have mild adverse effects. Numerous studies have demonstrated that traditional Chinese medicine (TCM) can control the gut microbiota in a multi-targeted and comprehensive manner, thereby restoring flora homeostasis, repairing damaged intestinal mucosal barriers, and eventually curbing the development of obesity. The active ingredients and compounds of TCM can restore the normal physiological function of the intestinal mucosal barrier by regulating gut microbiota to regulate energy metabolism, inhibit fat accumulation, affect food appetite, and reduce intestinal mucosal inflammatory response, thereby effectively promoting weight loss and providing new strategies for obesity prevention and treatment. Although there are some studies on the regulation of gut microbiota by TCM to prevent and treat obesity, all of them have the disadvantage of being systematic and comprehensive. Therefore, this work comprehensively describes the molecular mechanism of obesity mediated by gut microbiota based on the research state of obesity, gut microbiota, and TCM. A comprehensive and systematic summary of TCM targeting the regulation of gut microbiota for the treatment of obesity should be conducted in order to provide new strategies and ideas for the treatment of obesity.
Introduction: The Obesity-Dysbiosis Link
Obesity is a complex metabolic disease often characterized by "dysbiosis"—an imbalance in gut microbial communities. High-fat diets disrupt the intestinal barrier, allowing pro-inflammatory markers like lipopolysaccharides (LPS) to leak into the bloodstream, triggering systemic inflammation and metabolic dysfunction.
While conventional anti-obesity drugs exist, they are often limited by significant side effects (e.g., insomnia, anxiety, or gastrointestinal distress) and poor long-term efficacy. There is a critical need for a systematic understanding of how TCM, which has been used for centuries with relatively mild side effects, can serve as a multi-targeted therapeutic strategy to "reprogram" the gut environment for weight management.
Review Methodology
As a comprehensive review, this paper aggregates and categorizes findings from 114 peer-reviewed studies. The mechanisms of TCM-mediated obesity control are organized into four functional pillars:
- Regulation of energy absorption: How microbes harvest calories from the diet.
- Regulation of feeding behavior: The "brain-gut-bacteria" axis and appetite-regulating hormones.
- Regulation of fat accumulation: Molecular signaling in adipose tissue.
- Alleviation of chronic inflammation: Repairing the "leaky gut" and inhibiting pro-inflammatory cascades.
Key Mechanisms: The Gut-Microbiota-Host Axis
A primary insight of this research is the role of short-chain fatty acids (SCFAs)—acetate, propionate, and butyrate—as the primary signaling bridge between microbes and the host. TCM promotes bacteria that produce SCFAs, which then activate G-protein coupled receptors (GPR41/43) to increase energy expenditure and insulin sensitivity.
TCM also influences the brain-gut axis. Ingredients like ginsenosides and berberine increase the secretion of satiety hormones like Glucagon-like peptide-1 (GLP-1) and Peptide YY (PYY), signaling the brain to reduce food intake. Furthermore, TCM repairs the intestinal mucosal barrier by increasing the expression of tight junction proteins, preventing "metabolic endotoxemia"—the leakage of bacterial LPS into the blood—which is a root cause of obesity-related inflammation.
Therapeutic Outcomes of TCM Interventions
The review provides a detailed mapping of specific TCM interventions to metabolic outcomes:
- Ginsenosides: Upregulate PYY and GLP-1, targeting GPR41/43 to control energy absorption.
- Berberine & Curcumin: Improve intestinal barrier function and increase the abundance of beneficial probiotics.
- Atractylodes macrocephala: Increases brown fat cells and promotes thermogenesis via PGC-1α and UCP1 expression.
- Decoctions (e.g., Erchen, Xiexin): Demonstrate significant reductions in total cholesterol (TC) and triglycerides (TG) by modulating lipid metabolism genes.
- Polysaccharides: Ingredients from Ganoderma lucidum and Poria cocos improve gut flora diversity and inhibit pro-inflammatory cytokines like IL-6 and TNF-α.
Challenges and Future Directions
Several hurdles remain for the field to address:
- Complexity of Biotransformation: Because TCM often involves complex formulas, it is difficult to determine exactly how different bacteria metabolize these ingredients into active secondary metabolites.
- Direct vs. Indirect Effects: It remains challenging to decouple whether a TCM compound acts directly on host tissues or if its effects are entirely mediated by the microbiota.
- Lack of Human Data: Much of the current evidence relies on rodent models. More rigorous, large-scale clinical trials are needed to confirm these molecular mechanisms in humans.
- Systematic Integration: Future research must move toward a holistic systems-biology approach to understand the synergistic effects of complex TCM formulas.
Summary updated